Predictive factors of head and neck squamous cell carcinoma patient tolerance to high-dose cisplatin in concurrent chemoradiotherapy

Although high-dose cisplatin is the standard regimen of concurrent chemoradiotherapy (CCRT) for locally advanced head and neck squamous cell carcinoma (HNSCC), varying levels of patient tolerance towards cisplatin have been reported, and the predictive factors of cisplatin tolerance remain to be elu...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Mol Clin Oncol
Autori principali: NAKANO, KENJI, SATO, YASUYOSHI, TOSHIYASU, TAKASHI, SATO, YUKIKO, INAGAKI, LINA, TOMOMATSU, JUNICHI, SASAKI, TORU, SHIMBASHI, WATARU, FUKUSHIMA, HIROFUMI, YONEKAWA, HIROYUKI, MITANI, HIROKI, KAWABATA, KAZUYOSHI, TAKAHASHI, SHUNJI
Natura: Artigo
Lingua:Inglês
Pubblicazione: D.A. Spandidos 2016
Soggetti:
Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4734196/
https://ncbi.nlm.nih.gov/pubmed/26893880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2015.687
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi